ARCH-backed Autobahn launches with $76M to rebuild myelin and reverse MS
For decades, drugs for multiple sclerosis — and there have been many — have been almost exclusively band-aids: inhibitors designed to halt the damage before it got …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
